G16B 20/20
Allele or variant detection
Official title: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
G16B20/20 (Allele or variant detection) appears on 1,907 US grants and 5,126 published applications in this corpus.
Search patents in G16B- Granted patents
- 1,907
- Published applications
- 5,126
- Assignees
- 1,453
- Inventors
- 7,921
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 3 |
| 2002 | 6 | 35 |
| 2003 | 1 | 63 |
| 2004 | 8 | 47 |
| 2005 | 9 | 99 |
| 2006 | 20 | 105 |
| 2007 | 12 | 89 |
| 2008 | 19 | 150 |
| 2009 | 32 | 109 |
| 2010 | 56 | 135 |
| 2011 | 70 | 127 |
| 2012 | 58 | 128 |
| 2013 | 64 | 158 |
| 2014 | 85 | 230 |
| 2015 | 52 | 183 |
| 2016 | 55 | 232 |
| 2017 | 80 | 244 |
| 2018 | 93 | 252 |
| 2019 | 147 | 309 |
| 2020 | 145 | 331 |
| 2021 | 141 | 307 |
| 2022 | 173 | 332 |
| 2023 | 153 | 356 |
| 2024 | 169 | 368 |
| 2025 | 144 | 426 |
| 2026 | 107 | 308 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Molecular profiling of tumors6 Oct 2026US 12,754,193 B2Caris MPI, Inc.
- Systems and methods for predicting hematological conditions using methylation data6 Oct 2026US 12,755,820 B2H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Selection of cancer mutations for generation of a personalized cancer vaccine29 Sep 2026US 12,749,556 B2Nouscom AG
- Genotyping by sequencing22 Sep 2026US 12,742,195 B2Regeneron Pharmaceuticals, Inc.
- Method and kit for characterizing microorganisms22 Sep 2026US 12,742,210 B2Fry Laboratories, LLC
- Compositions and methods for assessing neuroinflammation using somatic mutations8 Oct 2026US 2026/0308681 A1Children's Medical Center Corporation
- Multiple-tiered screening and second analysis8 Oct 2026US 2026/0308698 A1Flagship Pioneering Innovations VI, LLC
- Systems and Methods For The Identification And Characterization Of Pathogens In Urine Samples To Inform Patient Treatment8 Oct 2026US 2026/0308700 A1Biotia, Inc.
- System and method for dual-threshold classification and refinement in streamed measurement datasets8 Oct 2026US 2026/0311802 A1Dana-Farber Cancer Institute, Inc.
- Computational methods for selecting personalized neoantigen vaccines8 Oct 2026US 2026/0311803 A1
Most cited
By later US patents
- CRISPR-Cas component systems, methods and compositions for sequence manipulation560US 8,795,965 B2Massachusetts Institute of Technology · 2014
- Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites556US 6,453,242 B1Sangamo BioSciences, Inc. · 2002
- CRISPR-Cas component systems, methods and compositions for sequence manipulation529US 8,871,445 B2Massachusetts Institute of Technology · 2014
- Method of tagging using a split DBR509US 8,741,606 B2Population Genetics Technologies Ltd · 2014
- Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation489US 8,865,406 B2Massachusetts Institute of Technology · 2014